Neumora Therapeutics, Inc. Other Noncash Expense
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashExpense · last filed 2026-03-30
- Neumora Therapeutics, Inc. other noncash expense for the quarter ending 2025-12-31 was -$7.00K, a 450.00% decline year-over-year.
- Neumora Therapeutics, Inc. other noncash expense for the quarter ending 2024-12-31 was $2.00K.
- Neumora Therapeutics, Inc. other noncash expense for fiscal 2025 was $32.00K, a 39.13% increase from fiscal 2024.
- Neumora Therapeutics, Inc. other noncash expense for fiscal 2024 was $23.00K.
| Period end | Other Noncash Expense 3 month | Other Noncash Expense 9 month | Other Noncash Expense 12 month |
|---|---|---|---|
| 2025-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $32.00K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $39.00K 10-Q · filed 2025-11-06 | ||
| 2024-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $23.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $21.00K 10-Q · filed 2025-11-06 |